Study cohort
arrhythmia, congenital heart disease, valvular disease, hypertensive
MAY, ARRHYTHMIA, CARDIOMYOPATHY
We prospectively recruited elderly hypertensive patients from the Guangdong clinical center for the STEP trial between May 2017 and January 2018. Previous research detailed the trial protocol and main findings.When BP control was achieved, patients volunteered for an echocardiogram at the 1‐year (phase 1) and 3‐year (phase 2) follow‐up after randomization. Severe valvular disease, cardiomyopathy, congenital heart disease, and arrhythmia were excluded. The (Supporting Information: Table 